An observational parallel group comparative study with and without the Magic Bullet (MB: Aspirin, cardio selective beta-blocker, Pravastatin and Clopidogrel) in the peri-operative and postoperative period for Abdominal Aortic aneurysms Surgery and femoral-popliteal segment revascularisation. Does the Magic Bullet improve the 30-day morbidity and mortality outcome?. Br J Surg

SHERIF SULTAN

An observational parallel group comparative study with and without the Magic Bullet (MB: Aspirin, cardio selective beta-blocker, Pravastatin and Clopidogrel) in the peri-operative and postoperative period for Abdominal Aortic aneurysms Surgery and femoral-popliteal segment revascularisation. Does the Magic Bullet improve the 30-day morbidity and mortality outcome?. Br J Surg

SHERIF SULTAN

Surgery

Research output: Other contribution (Published) › Other contribution

Original language	English (Ireland)
Media of output	Abstract
Number of pages	1
Volume	91
Publication status	Published - 1 Jan 2004

Cite this

SULTAN, SHERIF. (2004, Jan 1). An observational parallel group comparative study with and without the Magic Bullet (MB: Aspirin, cardio selective beta-blocker, Pravastatin and Clopidogrel) in the peri-operative and postoperative period for Abdominal Aortic aneurysms Surgery and femoral-popliteal segment revascularisation. Does the Magic Bullet improve the 30-day morbidity and mortality outcome?. Br J Surg.

SULTAN, SHERIF. / An observational parallel group comparative study with and without the Magic Bullet (MB: Aspirin, cardio selective beta-blocker, Pravastatin and Clopidogrel) in the peri-operative and postoperative period for Abdominal Aortic aneurysms Surgery and femoral-popliteal segment revascularisation. Does the Magic Bullet improve the 30-day morbidity and mortality outcome?. Br J Surg. 2004. 1 p.

@misc{8ad96eba17f840f9a5fdf2e3158e9ea9,

title = "An observational parallel group comparative study with and without the Magic Bullet (MB: Aspirin, cardio selective beta-blocker, Pravastatin and Clopidogrel) in the peri-operative and postoperative period for Abdominal Aortic aneurysms Surgery and femoral-popliteal segment revascularisation. Does the Magic Bullet improve the 30-day morbidity and mortality outcome?. Br J Surg",

author = "SHERIF SULTAN",

year = "2004",

month = jan,

day = "1",

language = "English (Ireland)",

volume = "91",

type = "Other",

}

SULTAN, SHERIF 2004, An observational parallel group comparative study with and without the Magic Bullet (MB: Aspirin, cardio selective beta-blocker, Pravastatin and Clopidogrel) in the peri-operative and postoperative period for Abdominal Aortic aneurysms Surgery and femoral-popliteal segment revascularisation. Does the Magic Bullet improve the 30-day morbidity and mortality outcome?. Br J Surg.

An observational parallel group comparative study with and without the Magic Bullet (MB: Aspirin, cardio selective beta-blocker, Pravastatin and Clopidogrel) in the peri-operative and postoperative period for Abdominal Aortic aneurysms Surgery and femoral-popliteal segment revascularisation. Does the Magic Bullet improve the 30-day morbidity and mortality outcome?. Br J Surg. / SULTAN, SHERIF.
1 p. 2004.

Research output: Other contribution (Published) › Other contribution

TY - GEN

T1 - An observational parallel group comparative study with and without the Magic Bullet (MB: Aspirin, cardio selective beta-blocker, Pravastatin and Clopidogrel) in the peri-operative and postoperative period for Abdominal Aortic aneurysms Surgery and femoral-popliteal segment revascularisation. Does the Magic Bullet improve the 30-day morbidity and mortality outcome?. Br J Surg

AU - SULTAN, SHERIF

PY - 2004/1/1

Y1 - 2004/1/1

M3 - Other contribution

VL - 91

ER -

SULTAN SHERIF. An observational parallel group comparative study with and without the Magic Bullet (MB: Aspirin, cardio selective beta-blocker, Pravastatin and Clopidogrel) in the peri-operative and postoperative period for Abdominal Aortic aneurysms Surgery and femoral-popliteal segment revascularisation. Does the Magic Bullet improve the 30-day morbidity and mortality outcome?. Br J Surg. 2004. 1 p.